| Enantioselective Oxidative (4+ 3) Cycloadditions between Allenamides and Furans through Bifunctional Hydrogen‐Bonding/Ion‐Pairing Interactions L Villar, U Uria, JI Martínez, L Prieto, E Reyes, L Carrillo, JL Vicario Angewandte Chemie 129 (35), 10671-10674, 2017 | 63 | 2017 |
| Bifunctional squaramide catalysts with the same absolute chirality for the diastereodivergent access to densely functionalised cyclohexanes through enantioselective domino … JI Martinez, L Villar, U Uria, L Carrillo, E Reyes, JL Vicario Advanced Synthesis & Catalysis 356 (17), 3627-3648, 2014 | 63 | 2014 |
| Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide Z Wang, Y Wang, P Vilekar, SP Yang, M Gupta, MI Oh, A Meek, L Doyle, ... PeerJ 8, e9533, 2020 | 32 | 2020 |
| Is Inhaled Furosemide a Potential Therapeutic for COVID-19? A Brennecke, L Villar, Z Wang, LM Doyle, A Meek, M Reed, C Barden, ... The American Journal of the Medical Sciences 360 (3), 216-221, 2020 | 21 | 2020 |
| Kinetic Resolution of Secondary Allyl Boronates and Their Application in the Synthesis of Homoallylic Amines L Villar, NV Orlov, NS Kondratyev, U Uria, JL Vicario, AV Malkov Chemistry–A European Journal 24 (61), 16262-16265, 2018 | 15 | 2018 |
| A Series of 2‐((1‐Phenyl‐1H‐imidazol‐5‐yl) methyl)‐1H‐indoles as Indoleamine 2, 3‐Dioxygenase 1 (IDO1) Inhibitors Y Zheng, PM Stafford, KR Stover, DC Mohan, M Gupta, EC Keske, ... ChemMedChem 16 (14), 2195-2205, 2021 | 9 | 2021 |
| A privileged dual action Alzheimer's disease therapeutic platform targeting immunopathic and proteopathic mechanisms: (E)-3-styrylindoles as inhibitors of … BJ Kelly, E Diez-Cecilia, L Pan, B Sweeting, L Villar, A Kreft, M Gupta, ... Canadian Journal of Chemistry 100 (9), 660-675, 2022 | 1 | 2022 |
| Furosemide analogues and compositions and uses thereof for treatment of alzheimer's disease DF Weaver, Z Wang, L Doyle, L Villar, PS Vilekar US Patent App. 17/620,103, 2022 | | 2022 |
| Front Cover: A Series of 2‐((1‐Phenyl‐1H‐imidazol‐5‐yl) methyl)‐1H‐indoles as Indoleamine 2, 3‐Dioxygenase 1 (IDO1) Inhibitors (ChemMedChem 14/2021) Y Zheng, PM Stafford, KR Stover, DC Mohan, M Gupta, EC Keske, ... ChemMedChem 16 (14), 2157-2157, 2021 | | 2021 |
| Combined Chemoenzymatic Sequence for the Synthesis of γ-Lactones V Snieckus, L Villar, DF Weaver Synfacts 16 (08), 0900, 2020 | | 2020 |
| Chemodivergent and Enantiospecific Synthesis of Benzazepines and Allyl Fluorides V Snieckus, L Villar, DF Weaver, MA Reed Synfacts 16 (04), 0387, 2020 | | 2020 |
| Selective Synthesis of Thio-Substituted Cyclotriphosphazene Derivatives V Snieckus, L Villar, DF Weaver, MA Reed Synfacts 15 (12), 1363, 2019 | | 2019 |
| Asymmetric Synthesis of Dihydrobenzofurans by an Organocatalytic [4+ 1] Cyclization V Snieckus, L Villar, DF Weaver, MA Reed Synfacts 15 (08), 0865, 2019 | | 2019 |
| Synthesis of Carbazoles and Indolines by Gold-Catalyzed Diels–Alder Reactions V Snieckus, L Villar, DF Weaver, MA Reed Synfacts 15 (04), 0360, 2019 | | 2019 |
| ALLYL BORONATES WITH A NEW DIOL'HELMET'AT BORON: IMPROVED STABILITY AND EASY ACCESS TO VARIOUS CHIRAL FUNCTIONALIZED COMPOUNDS NV Orlov, L Villar, NS Kondratyev, U Uria, JL Vicario, AV Malkov ChemTrends-2018, 38-38, 2018 | | 2018 |
| Kinetic resolution of chiral racemic secondary allylboronates and their application in the synthesis of homoallylic amines L Villar, NV Orlov, NS Kondratyev, JL Vicario, AV Malkov Loughborough University, 2017 | | 2017 |
| Catalytic stereoselective formation of CC and CN bonds in target-oriented synthesis L Villar, NV Orlov, N Kondratyev, JL Vicario, AV Malkov Advances in synthesis and complexing, 163-163, 2017 | | 2017 |
